Catherine Tralau-Stewart
Directeur Technique/Scientifique/R&D chez VALIRX PLC
Profil
Catherine Jane Tralau-Stewart is currently the Chief Scientific Officer at ValiRx Plc and a Member of the British Pharmacological Society.
She was previously the Chief Scientific Officer at C4X Discovery Holdings Plc.
Tralau-Stewart received her undergraduate and doctorate degrees from UCL Medical School.
Postes actifs de Catherine Tralau-Stewart
Sociétés | Poste | Début |
---|---|---|
VALIRX PLC | Directeur Technique/Scientifique/R&D | 08/09/2022 |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Anciens postes connus de Catherine Tralau-Stewart
Sociétés | Poste | Fin |
---|---|---|
C4X DISCOVERY HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 10/01/2023 |
Formation de Catherine Tralau-Stewart
UCL Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
C4X DISCOVERY HOLDINGS PLC | Health Technology |
VALIRX PLC | Health Technology |
Entreprise privées | 1 |
---|---|
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |